From the Department of Ophthalmology, Penn State College of Medicine, Hershey, Pennsylvania (Pantanelli, O'Rourke, Bolognia, Scruggs, Longenecker); Department of Public Health Sciences, Penn State College of Medicine, Hershey, Pennsylvania (Lehman).
J Cataract Refract Surg. 2023 Apr 1;49(4):360-366. doi: 10.1097/j.jcrs.0000000000001123. Epub 2022 Dec 21.
To compare outcomes in patients who underwent cataract extraction with implantation of nondiffractive extended depth-of-focus (ND-EDOF; Alcon AcrySof Vivity) or neutral aspheric monofocal (Bausch & Lomb enVista) intraocular lenses (IOLs).
Academic medical center.
Prospective single-center double-arm patient- and assessor-masked randomized controlled trial.
Patients were randomized to receive either a ND-EDOF or monofocal IOL in both eyes, targeted for emmetropia. Uncorrected and corrected (CDVA) distance visual acuities, distance-corrected intermediate visual acuity (DCIVA), distance-corrected near visual acuity (DCNVA), level of spectacle independence, and severity of photic phenomena were assessed at 3 months postoperatively.
56 patients were enrolled, of which 24 in the ND-EDOF group and 27 in the monofocal group completed follow-up. The binocular mean CDVA, DCIVA, and DCNVA were 20/20, 20/19, and 20/21 for the ND-EDOF IOL and 20/18 ( P = .188), 20/31 ( P < .001), and 20/30 ( P = .004) for the monofocal IOL, respectively. At intermediate, 88% of the ND-EDOF vs 30% of the monofocal patients had a binocular DCIVA of 20/25 or better ( P < .001). Moderate or severe glare occurred in 20.8% of ND-EDOF vs 7.4% of monofocal patients ( P = .228), whereas moderate or severe halos occurred in 16.7% of ND-EDOF vs 11.1% of monofocal patients ( P = .697).
The ND-EDOF and monofocal IOLs provided similarly excellent distance vision. Patients implanted with the ND-EDOF IOL had 2 more lines of vision at both intermediate and near, and a greater proportion reported spectacle independence. Most patients in both groups reported low severity of photic phenomena.
比较行白内障超声乳化摘除联合非衍射扩展景深(ND-EDOF;爱尔康 AcrySof Vivity)或中性非球面单焦点(博士伦 enVista)人工晶状体(IOL)植入的患者的结局。
学术医疗中心。
前瞻性单中心双臂患者和评估者盲法随机对照试验。
患者随机接受双眼 ND-EDOF 或单焦点 IOL 植入,目标为正视。术后 3 个月评估未矫正和矫正(CDVA)远视力、远距矫正中间视力(DCIVA)、远距矫正近视力(DCNVA)、眼镜独立程度和光幻视严重程度。
共纳入 56 例患者,其中 ND-EDOF 组 24 例,单焦点组 27 例完成随访。双眼平均 CDVA、DCIVA 和 DCNVA 分别为 ND-EDOF IOL 组的 20/20、20/19 和 20/21,单焦点 IOL 组为 20/18(P=0.188)、20/31(P<0.001)和 20/30(P=0.004)。在中间距离时,88%的 ND-EDOF 患者与 30%的单焦点患者具有 20/25 或更好的双眼 DCIVA(P<0.001)。20.8%的 ND-EDOF 患者发生中度或重度眩光,而 7.4%的单焦点患者发生中度或重度眩光(P=0.228),16.7%的 ND-EDOF 患者发生中度或重度晕光,而 11.1%的单焦点患者发生中度或重度晕光(P=0.697)。
ND-EDOF 和单焦点 IOL 均提供了极佳的远视力。植入 ND-EDOF IOL 的患者在中间和近距视力分别提高了 2 行,更大比例的患者报告不需要戴眼镜。两组患者大多数都报告光幻视严重程度较低。